Segmed is a RWE governance platform that provides clinical data and medical imaging for platform solutions.
Segmed has raised $10.4M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Segmed's investors include Y Combinator, Mighty Capital, Alchemist Accelerator, iGan Partners, Nina Capital.
Segmed is headquartered in Palo Alto, United States.
Segmed is a RWE governance platform that provides clinical data and medical imaging for platform solutions.
Segmed is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Segmed — Funding & Investors." VCBacked, September 3, 2024, https://www.vcbacked.co/company/segmed. Accessed October 18, 2026.
VCBacked. (2024). Segmed — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/segmed
{{cite web |title=Segmed — Funding & Investors |url=https://www.vcbacked.co/company/segmed |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated